Physician profile
Thomas M Basch
NPI 1619930575
$2,739.40
in general payments reported to CMS, 2019-2025
20 companies · $997 in 2025
The $997 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $60.53 · 2021: $125 · 2022: $175 · 2023: $35.00 · 2024: $1,178 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,667 · Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,666.82 |
| Food and Beverage | $543.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,181.99 | 2021-2025 | Proclaim, Eterna |
| Abbvie INC. | $88.50 | 2022-2023 | Ubrelvy |
| Allergan, INC. | $52.85 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $47.45 | 2019-2020 | |
| Biogen, INC. | $41.12 | 2021 | |
| Boston Scientific Corporation | $34.88 | 2021-2022 | |
| Piramal Critical Care | $31.66 | 2019 | |
| Vertical Pharmaceuticals, LLC | $29.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $29.07 | 2019-2022 | |
| Amgen INC. | $27.50 | 2022 | |
| Si-Bone, INC. | $27.43 | 2024 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.00 | 2022 | |
| Brainsway USA INC | $22.27 | 2022 | |
| Spinal Simplicity, LLC | $18.39 | 2024 | Ha Minuteman G3-R |
| Assertio Therapeutics, INC. | $15.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $14.06 | 2021 | |
| Curonix LLC | $13.61 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.47 | 2019 | |
| Collegium Pharmaceutical, INC. | $13.35 | 2020 | |
| Pfizer INC. | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Basch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.